Eby M - Search Results

1

pHUSH: a single vector system for conditional gene expression.

Gray DC, Hoeflich KP, Peng L, Gu Z, Gogineni A, Murray LJ, Eby M, Kljavin N, Seshagiri S, Cole MJ, Davis DP. Gray DC, et al. Among authors: eby m. BMC Biotechnol. 2007 Sep 26;7:61. doi: 10.1186/1472-6750-7-61. BMC Biotechnol. 2007. PMID: 17897455 Free PMC article.

2

Oncogenic BRAF is required for tumor growth and maintenance in melanoma models.

Hoeflich KP, Gray DC, Eby MT, Tien JY, Wong L, Bower J, Gogineni A, Zha J, Cole MJ, Stern HM, Murray LJ, Davis DP, Seshagiri S. Hoeflich KP, et al. Among authors: eby mt. Cancer Res. 2006 Jan 15;66(2):999-1006. doi: 10.1158/0008-5472.CAN-05-2720. Cancer Res. 2006. PMID: 16424035

3

Regulation of ERK3/MAPK6 expression by BRAF.

Hoeflich KP, Eby MT, Forrest WF, Gray DC, Tien JY, Stern HM, Murray LJ, Davis DP, Modrusan Z, Seshagiri S. Hoeflich KP, et al. Among authors: eby mt. Int J Oncol. 2006 Oct;29(4):839-49. Int J Oncol. 2006. PMID: 16964379

4

ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.

Dornan D, Shimizu H, Mah A, Dudhela T, Eby M, O'rourke K, Seshagiri S, Dixit VM. Dornan D, et al. Among authors: eby m. Science. 2006 Aug 25;313(5790):1122-6. doi: 10.1126/science.1127335. Science. 2006. PMID: 16931761

5

Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation.

Jaiswal BS, Janakiraman V, Kljavin NM, Chaudhuri S, Stern HM, Wang W, Kan Z, Dbouk HA, Peters BA, Waring P, Dela Vega T, Kenski DM, Bowman KK, Lorenzo M, Li H, Wu J, Modrusan Z, Stinson J, Eby M, Yue P, Kaminker JS, de Sauvage FJ, Backer JM, Seshagiri S. Jaiswal BS, et al. Among authors: eby m. Cancer Cell. 2009 Dec 8;16(6):463-74. doi: 10.1016/j.ccr.2009.10.016. Cancer Cell. 2009. PMID: 19962665 Free PMC article.

6

Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO.

Zhou H, Wertz I, O'Rourke K, Ultsch M, Seshagiri S, Eby M, Xiao W, Dixit VM. Zhou H, et al. Among authors: eby m. Nature. 2004 Jan 8;427(6970):167-71. doi: 10.1038/nature02273. Epub 2003 Dec 24. Nature. 2004. PMID: 14695475

7

De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.

Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, Ma A, Koonin EV, Dixit VM. Wertz IE, et al. Among authors: eby m. Nature. 2004 Aug 5;430(7000):694-9. doi: 10.1038/nature02794. Epub 2004 Jul 18. Nature. 2004. PMID: 15258597

8

Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.

Wertz IE, Kusam S, Lam C, Okamoto T, Sandoval W, Anderson DJ, Helgason E, Ernst JA, Eby M, Liu J, Belmont LD, Kaminker JS, O'Rourke KM, Pujara K, Kohli PB, Johnson AR, Chiu ML, Lill JR, Jackson PK, Fairbrother WJ, Seshagiri S, Ludlam MJ, Leong KG, Dueber EC, Maecker H, Huang DC, Dixit VM. Wertz IE, et al. Among authors: eby m. Nature. 2011 Mar 3;471(7336):110-4. doi: 10.1038/nature09779. Nature. 2011. PMID: 21368834

9

Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway.

Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, Hood L. Chaudhary PM, et al. Among authors: eby m. Immunity. 1997 Dec;7(6):821-30. doi: 10.1016/s1074-7613(00)80400-8. Immunity. 1997. PMID: 9430227 Free article.

10

Activation of the NF-kappaB pathway by caspase 8 and its homologs.

Chaudhary PM, Eby MT, Jasmin A, Kumar A, Liu L, Hood L. Chaudhary PM, et al. Among authors: eby mt. Oncogene. 2000 Sep 14;19(39):4451-60. doi: 10.1038/sj.onc.1203812. Oncogene. 2000. PMID: 11002417

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters